TickerFactsScreenerDevelopers

Denali Therapeutics Inc. (DNLI) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2016: $6.13M2017: $2.88M2018: $3.39M2019: $17.92M2020: $3.10M2021: $8.50M2022: $17.83M2023: $12.94M2024: $15.91M2025: $9.50M$9.50M
2016Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$9.50M-40.3%
2024$15.91M+23.0%
2023$12.94M-27.4%
2022$17.83M+109.8%
2021$8.50M+174.6%
2020$3.10M-82.7%
2019$17.92M+428.1%
2018$3.39M+18.0%
2017$2.88M-53.1%
2016$6.13M—